ZURICH Roche has bought Vienna-based diabetes government height mySugr for an undisclosed price, a Swiss drugmaker pronounced on Friday, fasten a flourishing throng of companies expanding into app-based digital health services.
Privately hold mySugr offers a logbook for mobile inclination to assistance people lane all from their blood sugar, drugs and activity levels. It has been operative with Roche given 2014 and formerly got appropriation from a Roche Venture Fund.
With a acquisition, Roche aims to strengthen a diabetes diagnostics business that has faced extreme cost vigour in new years, slicing into sales expansion and call rumors that it wants to unpack a business. Roche has pronounced it wants to enhance a unit, not sell it.
The takeover also reflects a latest pull by medical device makers seeking to strap wireless record and “big data”. Another diabetes tech startup, U.S.-based Glooko, has lured money from Medtronic and others for a identical height to conduct diabetes around smartphones.
The pull goes good over diabetes, too. Last year, Roche opposition Novartis assimilated Qualcomm to make an internet-enabled inhaler for a emphysema drug Onbrez that is due out in 2019. [reut.rs/1S8CEFu]
“We will be means to offer seamlessly permitted studious solutions within an open height to improved respond to a unmet needs of people with diabetes,” pronounced Roland Diggelmann, Roche’s diagnostics head.
MySugr now has some-more than a million users, co-founder Frank Westermann said. The company, with U.S. offices in San Diego, has 47 employees, with a app permitted in 52 countries and in 13 languages.
“With Roche’s diabetes imagination and tellurian network, mySugr will turn an indispensable companion,” Westermann pronounced in a statement.
With mySugr’s app, diabetes sufferers who use glucose meters to investigate their blood sugarine levels can automatically upload information around a Bluetooth tie to their smartphones.
From there, a information can also be common remotely with doctors operative with patients to conduct a disease.
MySugr will sojourn an open height permitted for other manufacturers’ inclination following a deal, Roche said.
But those who download a app have been means to get a Swiss company’s Accu-Chek-brand glucose meters for free, as Roche seeks to constraint some-more business for a glucose exam strips that diabetics contingency squeeze indefinitely.
(Reporting by John Miller; Editing by Michael Shields and Mark Potter)